| Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome B Linder, AV Grozhik, AO Olarerin-George, C Meydan, CE Mason, ... Nature methods 12 (8), 767-772, 2015 | 1347 | 2015 |
| The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight FE Garrett-Bakelman, M Darshi, SJ Green, RC Gur, L Lin, BR Macias, ... Science 364 (6436), eaau8650, 2019 | 874 | 2019 |
| Geospatial resolution of human and bacterial diversity with city-scale metagenomics E Afshinnekoo, C Meydan, S Chowdhury, D Jaroudi, C Boyer, N Bernstein, ... Cell systems 1 (1), 72-87, 2015 | 334 | 2015 |
| Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection V Ramlall, PM Thangaraj, C Meydan, J Foox, D Butler, J Kim, B May, ... Nature medicine 26 (10), 1609-1615, 2020 | 298 | 2020 |
| Fundamental biological features of spaceflight: advancing the field to enable deep-space exploration E Afshinnekoo, RT Scott, MJ MacKay, E Pariset, E Cekanaviciute, ... Cell 183 (5), 1162-1184, 2020 | 278 | 2020 |
| The spatial landscape of lung pathology during COVID-19 progression AF Rendeiro, H Ravichandran, Y Bram, V Chandar, J Kim, C Meydan, ... Nature 593 (7860), 564-569, 2021 | 277 | 2021 |
| CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ... Cancer discovery 7 (1), 38-53, 2017 | 259 | 2017 |
| Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia AH Shih, Y Jiang, C Meydan, K Shank, S Pandey, L Barreyro, ... Cancer cell 27 (4), 502-515, 2015 | 242 | 2015 |
| A global metagenomic map of urban microbiomes and antimicrobial resistance D Danko, D Bezdan, EE Afshin, S Ahsanuddin, C Bhattacharya, DJ Butler, ... Cell 184 (13), 3376-3393. e17, 2021 | 218 | 2021 |
| Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact WA da Silveira, H Fazelinia, SB Rosenthal, EC Laiakis, MS Kim, ... Cell 183 (5), 1185-1201. e20, 2020 | 217 | 2020 |
| Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence C Duy, M Li, M Teater, C Meydan, FE Garrett-Bakelman, TC Lee, CR Chin, ... Cancer discovery 11 (6), 1542-1561, 2021 | 163 | 2021 |
| Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis AD Viny, CJ Ott, B Spitzer, M Rivas, C Meydan, E Papalexi, D Yelin, ... Journal of Experimental Medicine 212 (11), 1819-1832, 2015 | 156 | 2015 |
| ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2 D Jain, MR Puno, C Meydan, N Lailler, CE Mason, CD Lima, ... elife 7, e30919, 2018 | 151 | 2018 |
| Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions D Butler, C Mozsary, C Meydan, J Foox, J Rosiene, A Shaiber, D Danko, ... Nature communications 12 (1), 1660, 2021 | 144 | 2021 |
| H1 histones control the epigenetic landscape by local chromatin compaction MA Willcockson, SE Healton, CN Weiss, BA Bartholdy, Y Botbol, ... Nature 589 (7841), 293-298, 2021 | 130 | 2021 |
| The metagenomics and metadesign of the subways and urban biomes (MetaSUB) international consortium inaugural meeting report Microbiome 4 (1), 24, 2016 | 123 | 2016 |
| Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response W Béguelin, M Teater, C Meydan, KB Hoehn, JM Phillip, AA Soshnev, ... Cancer cell 37 (5), 655-673. e11, 2020 | 118 | 2020 |
| Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia AH Shih, C Meydan, K Shank, FE Garrett-Bakelman, PS Ward, ... Cancer discovery 7 (5), 494-505, 2017 | 116 | 2017 |
| Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers JL Glass, D Hassane, BJ Wouters, H Kunimoto, R Avellino, ... Cancer discovery 7 (8), 868-883, 2017 | 114 | 2017 |
| Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity H Kunimoto, C Meydan, A Nazir, J Whitfield, K Shank, F Rapaport, ... Cancer cell 33 (1), 44-59. e8, 2018 | 90 | 2018 |
Christopher MasonProfessor of Genomics, Physiology, & Biophysics, Weill Cornell Medicine在 med.cornell.edu 的电子邮件经过验证
